Skip to Content


In some countries, this medicine may only be approved for veterinary use.

In the US, Spironolactone (spironolactone systemic) is a member of the following drug classes: aldosterone receptor antagonists, potassium-sparing diuretics and is used to treat Acne, Alopecia, Edema, Gender Dysphoria, Heart Failure, High Blood Pressure, Hirsutism, Hypokalemia, Primary Hyperaldosteronism and Primary Hyperaldosteronism Diagnosis.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Potassium-sparing diuretic agent, aldosterone antagonist

Chemical Name

Pregn-4-ene-21-carboxylic acid, 7-(acetyltio)-17-hydroxy-3-oxo-, t-lactone, (7α,17α)-

Foreign Names

Generic Names

  • Spironolactone (OS: BAN, DCF, JAN)
  • Spironolattone (OS: DCIT)
  • SC 9420 (IS)
  • Spironolacton (PH: Ph. Eur. 9)
  • Spironolactone (PH: BP 2018, JP XVII, Ph. Eur. 9, Ph. Int. 7, USP 41)
  • Spironolactonum (PH: Ph. Eur. 9, Ph. Int. 7)

Brand Names


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.